about
Loss-of-function mutations in APOC3, triglycerides, and coronary diseaseWhole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations.Imputation of coding variants in African Americans: better performance using data from the exome sequencing projectUse of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative.Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African AmericansOophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study.Vasomotor symptoms and coronary artery calcium in postmenopausal women.Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study.Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study.Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI)Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI).A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women.Fish intake and the risk of incident heart failure: the Women's Health Initiative.Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health InitiativeMediterranean and DASH diet scores and mortality in women with heart failure: The Women's Health InitiativeConjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialRacial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women's Health InitiativeRelationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A2 in the women's health initiativeEducation, income, and incident heart failure in post-menopausal women: the Women's Health Initiative Hormone Therapy Trials.Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational StudyProspective analysis of association between statin use and breast cancer risk in the women's health initiative.Use of hundreds of electrocardiographic biomarkers for prediction of mortality in postmenopausal women: the Women's Health Initiative.Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial.Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) studyInsulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women: A Cohort Study From the Women's Health Initiative.Fibrinogen may mediate the association between long sleep duration and coronary heart disease.Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]).Exemestane for breast-cancer prevention in postmenopausal women.Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsPhysical Activity and Body MassImpedance measurement of absolute blood flow using an angioplasty catheter: A validation studyMultiple Cardiac Myxomas with Multiple Recurrences: Unusual Presentation of a “Benign” TumorMulti-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration
P50
Q30408720-4A77EEFF-0096-4BA3-8A57-B9A05E41CC81Q30411390-0AAF180C-7648-42C7-A1C4-C48A1609FD4BQ30414381-5E6B004C-81A4-4948-9DD1-0D4FA29517D9Q30662194-D2E60F7C-E2D3-4946-A5D9-88E60275B197Q30727710-286AB693-4810-47FE-AA6E-33C00355764EQ33750151-C78F591F-0125-4194-A21B-A8EA42AC38CDQ33925367-472BEC43-1494-410A-BB69-B5FAD2B99136Q34180408-1000627B-751D-447E-BB8C-905A24D18BD8Q34565965-3765BFB2-B622-4DAB-950B-2E917B73D0EDQ34627340-7331D1BC-5AEA-4D9E-8426-B4632F5A851FQ34788703-5199648A-0F1A-430D-8D30-6CA5E70F1768Q34955404-2E53090D-5DEC-46A8-8D87-B151358287D1Q35080313-B7D3306D-F43C-42A6-866D-B3723AC26FDAQ35656420-53F0F7F6-3821-406A-B72B-922D44EBBB2CQ35793003-FD68A225-1814-4662-82ED-4849764A324DQ35846185-BF2EE0F7-40F5-4B6D-A116-EFBC830795ABQ35858718-6C3B30E1-92B6-4210-BEA6-02C1AB08A4A8Q35884178-611EBB34-6812-4383-8AB9-04DBA5531766Q36041352-F1665445-FB0F-4AA4-95E3-31EB873B7CE0Q36143058-8A367642-E332-4B9C-9805-32D396C663D1Q36201155-9819B5C7-B665-4A76-8488-51EED2EEB7C6Q36352735-39715A51-712A-4953-A397-AA572EEF7C09Q36565883-D0895AB2-BCE5-454F-A0B0-BBFD483FDA13Q36792127-1D89381A-5A63-43B1-AC64-05F8281A3DF8Q37412972-79DC9540-973A-4FCC-94F8-A9B1E4B5E2F9Q37467715-33AB5372-FC8F-4872-A31F-F19F955013C1Q37486205-B91BF8CB-8B83-4314-A9C8-B40D63F2F547Q37585388-F9BC946A-1AF9-4820-A934-1F1FFCA0B4CAQ37658616-3C53AC1F-0B99-4B5C-A932-ACF961CE22B5Q37671427-23BAC2D1-FF8B-4A14-B402-7C1E1F3A5E68Q38412013-FDE7A849-AF0B-4106-9D80-A37A7D73BBECQ48207950-5193AC1B-6A38-4878-8C93-6B975CEF5F13Q48633713-73C8819E-CE0F-449C-BFCF-E88FBD89BAF6Q48657440-145BC5FE-5F40-46A4-959B-C7CB2AA65DB6Q51924186-7F613CC3-752C-4DCB-BA28-A08DCB162439Q57616743-C654EE28-5939-4DB1-936E-9B9817F88C8DQ61479398-3B78A2CB-DA9F-4CE3-BA05-23F533C12B91Q61479412-C61C60A5-EC28-4C96-9600-7D8038ED2A22Q61479413-01A095FF-6593-4D82-9310-1DCC6BD5B27EQ91260159-25356797-5A4A-42BA-B622-B8FE18A31F95
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lisa W Martin
@es
Lisa W Martin
@nl
Lisa W Martin
@sl
Lisa W. Martin
@en
type
label
Lisa W Martin
@es
Lisa W Martin
@nl
Lisa W Martin
@sl
Lisa W. Martin
@en
prefLabel
Lisa W Martin
@es
Lisa W Martin
@nl
Lisa W Martin
@sl
Lisa W. Martin
@en
P106
P1153
35782178900
P21
P31
P496
0000-0003-4352-0914
P569
2000-01-01T00:00:00Z